EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Mitochondrial myopathy biomarkers

Marco Refrigeri, Alessandra Tola, Rosangela Mogavero, Maria Michela Pietracupa, Giulia Gionta, Roberto Scatena

Advances in Clinical Chemistry · 2026

DOI: 10.1016/bs.acc.2026.01.007 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advances in Clinical Chemistry, 2026. Verfasst von Marco Refrigeri und 5 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Pathology Department, Vannini Hospital, Rome, Italy. Hauptthemen laut MEDLINE: Mitochondrial Myopathies, Biomarkers. Die Arbeit nennt 66 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitochondrial myopathies comprise a heterogeneous group of disorders arising from structural or functional mitochondrial impairments that disrupt oxidative phosphorylation and cellular ATP production. The resulting energy deficit manifests not only in muscle but frequently leads to multi-systemic disease involving the brain, heart, kidneys, and endocrine system, creating a complex and often confounding clinical presentation. A critical, often overlooked aspect of their pathophysiology is that mitochondrial dysfunction extends far beyond bioenergetics. These organelles are vital hubs for biosynthetic pathways, calcium homeostasis, thermogenesis, apoptosis, and redox-sensitive signaling pathways that govern gene expression. The disruption of these integrated functions, whose molecular consequences are still being elucidated, is central to the disease's progression and heterogeneity. This clinical and molecular complexity contributes to significant diagnostic delay, with many remaining undiagnosed. Therefore, the development and strategic implementation of reliable biomarkers are essential. This review critically evaluates current and emerging biomarkers, proposing a diagnostic framework designed to improve diagnostic accuracy, limit unnecessary procedures, and ensure timely access to therapeutic interventions and genetic counseling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mitochondrial MyopathiesBiomarkersHumansAnimalsDNA, Mitochondrial

Stichwörter der Autor:innen

BiomarkersCell-free circulating mtDNACreatineDiagnosisExercise intoleranceFGF21GDF-15GeneticsMitochondrial diseaseMitochondrial medicineMitochondrial myopathyNeurofilamentsOxidative phosphorylation

Substanzen

BiomarkersDNA, Mitochondrial

Autor:innen und Institutionen

  • Clinical Pathology Department, Vannini Hospital, Rome, Italy.
  • Clinical Pathology Department, Vannini Hospital, Rome, Italy. Electronic address: roberto.a.scatena@gmail.com.

Zitieren

APA

Refrigeri, M., Tola, A., Mogavero, R., Pietracupa, M. M., Gionta, G., & Scatena, R. (2026). Mitochondrial myopathy biomarkers. Advances in Clinical Chemistry. https://doi.org/10.1016/bs.acc.2026.01.007

Vancouver

Refrigeri M, Tola A, Mogavero R, Pietracupa MM, Gionta G, Scatena R. Mitochondrial myopathy biomarkers. Advances in Clinical Chemistry. 2026. doi:10.1016/bs.acc.2026.01.007

BibTeX
@article{Refrigeri2026,
  author = {Refrigeri, Marco and Tola, Alessandra and Mogavero, Rosangela and Pietracupa, Maria Michela and Gionta, Giulia and Scatena, Roberto},
  title = {Mitochondrial myopathy biomarkers},
  journal = {Advances in Clinical Chemistry},
  year = {2026},
  doi = {10.1016/bs.acc.2026.01.007}
}
Kostenlos starten →